Products available in Hong Kong (Please consult physician for further information on prescription products):
Date of Approval: Nov 2022
If you think you may have experienced an adverse event (‘side effect’) after taking or using an Amgen product
please call 800 961 142 , email: medinfo.JAPAC@amgen.com.
If you want to contact Amgen for any of the following reasons:
Amgen is committed to patient Safety and the Global Patient Safety Department is responsible for oversight of Pharmacovigilance activity. Patient safety is our highest priority. To fulfill our commitment to patient safety, Amgen’s Global Patient Safety Team applies a comprehensive, continuous and rigorous approach to pharmacovigilance.